First Clinical Experience With Non-Invasive, Contactless, Optical, Surveillance Of Vascular Access – Patensee

Skip to content

Menu

Guarding the Lifeline of Dialysis Patients

Home
Team
Technology
News
Contact

Close Menu

Publication

Date

Link to Article

Scientific Publication

February, 2022

Original Article

Related Posts

Scientific Publication

HYBRID ILLUMINATION DLP ARCHITECTURE FOR NON-INVASIVE, OPTICAL SURVEILLANCE SYSTEM OF VASCULAR ACCESS FOR HEMODIALYSIS PATIENTS

Home
Team
Technology
News
Contact

© Patensee 2024

Powered by: SPInc

PatenSee is an emerging, clinical-stage, startup company with a novel, contactless imaging device for the early detection of vascular access complications in hemodialysis patients. The technology uses a unique data stream to mimic a best practice, physical examination. PatenSee recently signed a clinical collaboration agreement with Fresenius Medical Care, following the completion of a POC clinical trial with very promising results.

PatenSee is a portfolio company of MEDX Xelerator, a medical device incubator backed by Boston Scientific, Sheba Medical Center, MEDX Ventures Group, Consensus Business Group (CBG), West Pharmaceuticals and The Portland Trust.